Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T08:42:52.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision history updated to add v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T19:33:35.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Fallopian tube cancer added to the study keywords; the record revision updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-13T12:51:18.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma to the terminology and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-06T09:10:40.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 on the page header.
    Difference
    0.0%
    Check dated 2026-01-15T05:09:19.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    Locations were consolidated into one Locations section with individual state subsections (California, Massachusetts, Nevada, Ohio, Oklahoma, Pennsylvania). This update is part of revision v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-17T19:53:39.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.